APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Invasive Fungal Disease (IFD) Infection Diagnostic Reagent

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Market Analysis and Forecast 2026-2032

Report ID 173910580222 December 2025198 pages

Choose your research edition.

Industry ResearchInvasive Fungal Disease (IFD) Infection Diagnostic Reagent Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Industry Growth and Trends Forecast to 203287 pages · $3,450 USDMarket StructureGlobal Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Invasive Fungal Disease (IFD) Infection Diagnostic Reagent is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Invasive Fungal Disease (IFD) Infection Diagnostic Reagent is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Invasive Fungal Disease (IFD) Infection Diagnostic Reagent is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Invasive Fungal Disease (IFD) Infection Diagnostic Reagent is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Invasive Fungal Disease (IFD) Infection Diagnostic Reagent include GOLD MOUNTAINRIVER, Dynamiker Biotechnology, Zhanjiang A&C Biological LTD, IMMY and BioRad, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Invasive Fungal Disease (IFD) Infection Diagnostic Reagent, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Invasive Fungal Disease (IFD) Infection Diagnostic Reagent, also provides the revenue of main regions and countries. Of the upcoming market potential for Invasive Fungal Disease (IFD) Infection Diagnostic Reagent, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Invasive Fungal Disease (IFD) Infection Diagnostic Reagent revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Invasive Fungal Disease (IFD) Infection Diagnostic Reagent revenue, projected growth trends, production technology, application and end-user industry.

Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Segment by Company

GOLD MOUNTAINRIVER

Dynamiker Biotechnology

Zhanjiang A&C Biological LTD

IMMY

BioRad

Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Segment by Method

G Experimental

GM Experimental

Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Segment by Application

Hospital

Laboratory

Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Invasive Fungal Disease (IFD) Infection Diagnostic Reagent and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Invasive Fungal Disease (IFD) Infection Diagnostic Reagent.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Invasive Fungal Disease (IFD) Infection Diagnostic Reagent in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Invasive Fungal Disease (IFD) Infection Diagnostic Reagent company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Invasive Fungal Disease (IFD) Infection Diagnostic Reagent revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Market Size Growth Rate by Method (US$ Million), 2021 VS 2025 VS 2032 Table 2. G Experimental Major Player Table 3. GM Experimental Major Player Table 4. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Player Table 6. Laboratory Major Player Table 7. Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Industry Trends Table 8. Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Industry Drivers Table 9. Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Industry Opportunities and Challenges Table 10. Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Industry Restraints Table 11. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Market Size by Region (2021-2026) & (US$ Million) Table 13. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Market Share by Region (2021-2026) Table 14. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Market Size by Region (2027-2032) & (US$ Million) Table 15. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Market Share by Region (2027-2032) Table 16. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Players (US$ Million) & (2021-2026) Table 17. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue Market Share by Players (2021-2026) Table 18. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Key Players Ranking, 2024 VS 2025 VS 2026 Table 19. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Key Players Headquarters & Area Served Table 20. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Players, Product Type & Application Table 21. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Players Establishment Date Table 22. Global Players Market Concentration Ratio (CR5 and HHI) Table 23. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 24. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Method 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Method (2021-2026) & (US$ Million) Table 26. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Method (2027-2032) & (US$ Million) Table 27. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue Market Share by Method (2021-2026) Table 28. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue Market Share by Method (2027-2032) Table 29. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Application (2021-2026) & (US$ Million) Table 31. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Application (2027-2032) & (US$ Million) Table 32. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue Market Share by Application (2021-2026) Table 33. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue Market Share by Application (2027-2032) Table 34. GOLD MOUNTAINRIVER Company Information Table 35. GOLD MOUNTAINRIVER Business Overview Table 36. GOLD MOUNTAINRIVER Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. GOLD MOUNTAINRIVER Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Product Portfolio Table 38. GOLD MOUNTAINRIVER Recent Development Table 39. Dynamiker Biotechnology Company Information Table 40. Dynamiker Biotechnology Business Overview Table 41. Dynamiker Biotechnology Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Dynamiker Biotechnology Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Product Portfolio Table 43. Dynamiker Biotechnology Recent Development Table 44. Zhanjiang A&C Biological LTD Company Information Table 45. Zhanjiang A&C Biological LTD Business Overview Table 46. Zhanjiang A&C Biological LTD Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Zhanjiang A&C Biological LTD Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Product Portfolio Table 48. Zhanjiang A&C Biological LTD Recent Development Table 49. IMMY Company Information Table 50. IMMY Business Overview Table 51. IMMY Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. IMMY Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Product Portfolio Table 53. IMMY Recent Development Table 54. BioRad Company Information Table 55. BioRad Business Overview Table 56. BioRad Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. BioRad Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Product Portfolio Table 58. BioRad Recent Development Table 59. North America Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Method (2021-2026) & (US$ Million) Table 60. North America Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Method (2027-2032) & (US$ Million) Table 61. North America Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Application (2021-2026) & (US$ Million) Table 62. North America Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Application (2027-2032) & (US$ Million) Table 63. North America Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 64. North America Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Country (2021-2026) & (US$ Million) Table 65. North America Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Country (US$ Million) & (2027-2032) Table 66. Europe Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Method (2021-2026) & (US$ Million) Table 67. Europe Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Method (2027-2032) & (US$ Million) Table 68. Europe Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Application (2021-2026) & (US$ Million) Table 69. Europe Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Application (2027-2032) & (US$ Million) Table 70. Europe Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 71. Europe Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Country (2021-2026) & (US$ Million) Table 72. Europe Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Country (US$ Million) & (2027-2032) Table 73. China Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Method (2021-2026) & (US$ Million) Table 74. China Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Method (2027-2032) & (US$ Million) Table 75. China Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Application (2021-2026) & (US$ Million) Table 76. China Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Application (2027-2032) & (US$ Million) Table 77. Asia Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Method (2021-2026) & (US$ Million) Table 78. Asia Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Method (2027-2032) & (US$ Million) Table 79. Asia Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Application (2021-2026) & (US$ Million) Table 80. Asia Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Application (2027-2032) & (US$ Million) Table 81. Asia Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 82. Asia Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Region (US$ Million) & (2021-2026) Table 83. Asia Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Region (US$ Million) & (2027-2032) Table 84. SAMEA Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Method (2021-2026) & (US$ Million) Table 85. SAMEA Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Method (2027-2032) & (US$ Million) Table 86. SAMEA Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Application (2021-2026) & (US$ Million) Table 87. SAMEA Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Application (2027-2032) & (US$ Million) Table 88. SAMEA Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 89. SAMEA Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Country (2021-2026) & (US$ Million) Table 90. SAMEA Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Country (US$ Million) & (2027-2032) Table 91. Research Programs/Design for This Report Table 92. Authors List of This Report Table 93. Secondary Sources Table 94. Primary Sources List of Figures Figure 1. Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Image Figure 2. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Market Size Growth Rate by Method (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Market Size Share 2021 VS 2025 VS 2032 Figure 4. G Experimental Image Figure 5. GM Experimental Image Figure 6. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Laboratory Image Figure 10. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Market Size (US$ Million) & (2021-2032) Figure 11. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Market Share by Region: 2021 VS 2025 VS 2032 Figure 13. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Players Revenue Share Top 10 and Top 5 in 2025 Figure 14. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 15. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Method (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue Market Share by Method (2021-2032) Figure 18. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 20. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue Market Share by Application (2021-2032) Figure 21. North America Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue YoY Growth (2021-2032) & (US$ Million) Figure 22. North America Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue Share by Type (2021-2032) Figure 23. North America Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue Share by Application (2021-2032) Figure 24. North America Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue Share by Country (2021-2032) Figure 25. United States Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue YoY Growth (US$ Million) & (2021-2032) Figure 26. Canada Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Mexico Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Europe Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue YoY Growth (2021-2032) & (US$ Million) Figure 29. Europe Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue Share by Type (2021-2032) Figure 30. Europe Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue Share by Application (2021-2032) Figure 31. Europe Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue Share by Country (2021-2032) Figure 32. Germany Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. France Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. U.K. Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Italy Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Spain Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Russia Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Netherlands Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Nordic Countries Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. China Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue YoY Growth (2021-2032) & (US$ Million) Figure 41. China Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue Share by Type (2021-2032) Figure 42. China Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue Share by Application (2021-2032) Figure 43. Asia Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. Asia Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue Share by Type (2021-2032) Figure 45. Asia Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue Share by Application (2021-2032) Figure 46. Asia Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue Share by Region (2021-2032) Figure 47. Japan Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue YoY Growth (US$ Million) & (2021-2032) Figure 48. South Korea Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. India Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. Australia Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Taiwan Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Southeast Asia Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. SAMEA Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue YoY Growth (2021-2032) & (US$ Million) Figure 54. SAMEA Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue Share by Type (2021-2032) Figure 55. SAMEA Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue Share by Application (2021-2032) Figure 56. SAMEA Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue Share by Country (2021-2032) Figure 57. Brazil Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Argentina Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Chile Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Colombia Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Peru Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Saudi Arabia Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Israel Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. UAE Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Turkey Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Iran Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Egypt Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Years Considered Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • G Experimental
  • GM Experimental
Applications
  • Hospital
  • Laboratory
Companies covered
  • GOLD MOUNTAINRIVER
  • Dynamiker Biotechnology
  • Zhanjiang A&C Biological LTD
  • IMMY
  • BioRad

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Market by Method
  3. 1.2.1 Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Market Size by Method, 2021 VS 2025 VS 2032
  4. 1.2.2 G Experimental
  5. 1.2.3 GM Experimental
  6. 1.3 Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Market by Application
  7. 1.3.1 Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Laboratory
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Market Dynamics
  1. 2.1 Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Industry Trends
  2. 2.2 Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Industry Drivers
  3. 2.3 Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Industry Opportunities and Challenges
  4. 2.4 Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Market Perspective (2021-2032)
  2. 3.2 Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Growth Trends by Region
  3. 3.2.1 Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Market Size by Region (2021-2026)
  5. 3.2.3 Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Players
  2. 4.1.1 Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Players (2021-2026)
  3. 4.1.2 Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Key Players Headquarters & Area Served
  7. 4.4 Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Players, Product Type & Application
  8. 4.5 Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Market CR5 and HHI
  11. 4.6.3 2025 Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Tier 1, Tier 2, and Tier 3
5 Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Market Size by Type
  1. 5.1 Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Type (2021-2032)
  3. 5.3 Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue Market Share by Type (2021-2032)
6 Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Market Size by Application
  1. 6.1 Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Application (2021-2032)
  3. 6.3 Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 GOLD MOUNTAINRIVER
  2. 7.1.1 GOLD MOUNTAINRIVER Company Information
  3. 7.1.2 GOLD MOUNTAINRIVER Business Overview
  4. 7.1.3 GOLD MOUNTAINRIVER Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue and Gross Margin (2021-2026)
  5. 7.1.4 GOLD MOUNTAINRIVER Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Product Portfolio
  6. 7.1.5 GOLD MOUNTAINRIVER Recent Developments
  7. 7.2 Dynamiker Biotechnology
  8. 7.2.1 Dynamiker Biotechnology Company Information
  9. 7.2.2 Dynamiker Biotechnology Business Overview
  10. 7.2.3 Dynamiker Biotechnology Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Dynamiker Biotechnology Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Product Portfolio
  12. 7.2.5 Dynamiker Biotechnology Recent Developments
  13. 7.3 Zhanjiang A&C Biological LTD
  14. 7.3.1 Zhanjiang A&C Biological LTD Company Information
  15. 7.3.2 Zhanjiang A&C Biological LTD Business Overview
  16. 7.3.3 Zhanjiang A&C Biological LTD Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Zhanjiang A&C Biological LTD Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Product Portfolio
  18. 7.3.5 Zhanjiang A&C Biological LTD Recent Developments
  19. 7.4 IMMY
  20. 7.4.1 IMMY Company Information
  21. 7.4.2 IMMY Business Overview
  22. 7.4.3 IMMY Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue and Gross Margin (2021-2026)
  23. 7.4.4 IMMY Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Product Portfolio
  24. 7.4.5 IMMY Recent Developments
  25. 7.5 BioRad
  26. 7.5.1 BioRad Company Information
  27. 7.5.2 BioRad Business Overview
  28. 7.5.3 BioRad Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue and Gross Margin (2021-2026)
  29. 7.5.4 BioRad Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Product Portfolio
  30. 7.5.5 BioRad Recent Developments
8 North America
  1. 8.1 North America Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue (2021-2032)
  2. 8.2 North America Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Method (2021-2032)
  3. 8.2.1 North America Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Method (2021-2026)
  4. 8.2.2 North America Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Method (2027-2032)
  5. 8.3 North America Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue Share by Method (2021-2032)
  6. 8.4 North America Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Application (2021-2032)
  7. 8.4.1 North America Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Application (2021-2026)
  8. 8.4.2 North America Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Application (2027-2032)
  9. 8.5 North America Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue Share by Application (2021-2032)
  10. 8.6 North America Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Country
  11. 8.6.1 North America Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Country (2021-2026)
  13. 8.6.3 North America Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue (2021-2032)
  2. 9.2 Europe Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Method (2021-2032)
  3. 9.2.1 Europe Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Method (2021-2026)
  4. 9.2.2 Europe Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Method (2027-2032)
  5. 9.3 Europe Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue Share by Method (2021-2032)
  6. 9.4 Europe Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Application (2021-2032)
  7. 9.4.1 Europe Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Application (2021-2026)
  8. 9.4.2 Europe Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Application (2027-2032)
  9. 9.5 Europe Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue Share by Application (2021-2032)
  10. 9.6 Europe Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Country
  11. 9.6.1 Europe Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Country (2021-2026)
  13. 9.6.3 Europe Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue (2021-2032)
  2. 10.2 China Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Method (2021-2032)
  3. 10.2.1 China Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Method (2021-2026)
  4. 10.2.2 China Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Method (2027-2032)
  5. 10.3 China Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue Share by Method (2021-2032)
  6. 10.4 China Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Application (2021-2032)
  7. 10.4.1 China Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Application (2021-2026)
  8. 10.4.2 China Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Application (2027-2032)
  9. 10.5 China Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue (2021-2032)
  2. 11.2 Asia Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Method (2021-2032)
  3. 11.2.1 Asia Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Method (2021-2026)
  4. 11.2.2 Asia Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Method (2027-2032)
  5. 11.3 Asia Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue Share by Method (2021-2032)
  6. 11.4 Asia Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Application (2021-2032)
  7. 11.4.1 Asia Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Application (2021-2026)
  8. 11.4.2 Asia Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Application (2027-2032)
  9. 11.5 Asia Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue Share by Application (2021-2032)
  10. 11.6 Asia Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Country
  11. 11.6.1 Asia Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Country (2021-2026)
  13. 11.6.3 Asia Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue (2021-2032)
  2. 12.2 SAMEA Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Method (2021-2032)
  3. 12.2.1 SAMEA Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Method (2021-2026)
  4. 12.2.2 SAMEA Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Method (2027-2032)
  5. 12.3 SAMEA Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue Share by Method (2021-2032)
  6. 12.4 SAMEA Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Application (2027-2032)
  9. 12.5 SAMEA Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Country
  11. 12.6.1 SAMEA Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst